Fujiwara Y, Suzuki K, Yusa K, Eizuka M, et al. Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy. Intern Med 2021;60:1027-1033.
PMID: 33790139